UIH(SH:688271) 华尔街见闻·2025-05-03 23:32Core Viewpoint - The medical imaging equipment price war is intensifying, particularly affecting domestic manufacturers like United Imaging Healthcare and Wandong Medical, as evidenced by significant price drops in recent bidding events [1][4][5]. Group 1: Market Dynamics - In a recent procurement event in Fujian, Wandong Medical won a bid for 43 units of 1.5T MR equipment at a total of 118 million yuan, with the unit price dropping to 2 million yuan, a nearly 40% decrease from previous bids [2][3]. - The price competition is putting pressure on United Imaging Healthcare, which has seen its first annual revenue decline since its listing, with projected revenues and net profits for 2024 down 9.73% and 37.21% respectively [5]. - The CT market is also experiencing fierce competition, with significant price reductions observed in recent bids, such as the Insitum CT 568 being bid at 1.8 million yuan, down from previous prices [11][13][14]. Group 2: Future Outlook - The medical imaging sector may face a "bloodbath" in 2025 as procurement activities resume, potentially leading to shifts in market share [7]. - Despite the challenges, United Imaging Healthcare reported a slight recovery in early 2025, with revenues and net profits increasing by 5.42% and 1.87% year-on-year [6][28]. - The overall procurement scale for medical devices is expected to grow significantly, with a projected 49% increase in December 2024 compared to the previous year [27]. Group 3: Competitive Landscape - The MR market in China has significant growth potential, with a current penetration rate of only 12.4 units per million people, compared to 1/6 of the US and 1/4 of Japan [16]. - The competition in the 1.5T MR segment is intensifying, with Wandong Medical's recent bid breaking previous low-price records, indicating a trend towards lower pricing strategies [19][20]. - United Imaging Healthcare maintains a competitive edge in the high-end market, particularly with its exclusive position in the 5.0T MR segment [22][23]. Group 4: Strategic Responses - To counteract competitive pressures, United Imaging Healthcare is expanding its international presence, with overseas sales reaching 2.22 billion yuan, a year-on-year increase of over 30% [31]. - The company is also investing in local production capabilities in Southeast Asia and Latin America, aiming to build a robust overseas supply chain [33].